Compugen Ltd. CGEN
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- +20.26%
- 1 year
- +21.05%
Held by funds
6 US ETFs and mutual funds hold CGEN · largest positions
Ownership
- Institutions 15.0%
- Insiders 5.38%
- Public and other holders 79.7%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SilverArc Capital Management, LLC | 1.68% | 1,501,113 | 2.28M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.44% | 1,287,100 | 1.96M | Sep 29, 2024 |
| Taylor Frigon Capital Management LLC | 1.34% | 1,201,523 | 1.83M | Sep 29, 2024 |
| ARK Investment Management, LLC | 1.22% | 1,092,183 | 1.66M | Sep 29, 2024 |
| Macquarie Group Limited | 1.14% | 1,020,000 | 1.55M | Sep 29, 2024 |
| Rock Springs Capital Management, LP | 1.11% | 989,990 | 1.50M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Delaware Group Equity Fds IV-Delaware Healthcare Fund | 1.14% | 1,020,000 | 1.55M | Sep 29, 2024 |
| ARK ETF Tr-ARK Israel Innovative Technology ETF | 0.58% | 514,891 | 782.63K | Oct 30, 2024 |
| PFS Funds-Taylor Frigon Core Growth Fund | 0.27% | 242,969 | 369.31K | Aug 30, 2024 |
| DFA Continental Small Company Series | 0.15% | 131,543 | 199.94K | Jul 30, 2024 |
| SPDR Portfolio Developed World ex-US ETF | 0.12% | 106,691 | 162.17K | Sep 29, 2024 |
| DFA International Core Equity Portfolio | 0.09% | 81,192 | 123.41K | Jul 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs CGEN, and what each was last paid
Eran Ophir, Chief Executive Officer, President & DirectorAverage age 52
| Name | Title | Pay | Age |
|---|---|---|---|
| Eran Ophir | Chief Executive Officer, President & Director | $410K | 48 |
| Anat Cohen-Dayag | Executive Chair | $616K | 59 |
| Michelle Mahler | Chief Medical Officer | $535K | — |
| Pierre Ferre | Chief Operating Officer | $486K | 49 |
| Zurit Levine | Senior Vice President of Business Development | $313K | 58 |
| Rivka Schwartz | Vice President Research and Discovery | — | — |
| David Silberman | Chief Financial Officer | — | 42 |
| Lindsey Trickett | Head of Investor Relations and Corporate Communications | — | — |
| Eran Ben Dor | General Counsel & Corporate Secretary | — | — |
| Dorit Amitay | Vice President of Human Resources | — | 58 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
No insider holdings on record
